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Some hemodynamic determinants of immune complex trapping
by the kidney. This study was undertaken to help clarify the rela-
tionship between capillary hemodynamic events and the tissue
uptake of circulating immune complexes (IC). In each of 23 dogs,
bovine serum albumin (BSA) and rabbit antiBSA soluble IC la-
beled with 125J were given by constant iv. infusion, and IC up-
take by a normally perfused kidney was compared to that of the
contralateral kidney in which renal blood flow (RBF) was
changed by renal artery constriction or raised ureteral pressure.
In these same animals, IC uptake in 15 other major organ sys-
tems was also measured simultaneously. During IC infusion mi-
crospheres of 85Sr were injected to measure cardiac output and
tissue blood flow, and red cells labeled with 51Cr were infused to
mark tissue vascular volume. At completion of the IC infusion,
tissue samples were taken from the kidneys and the 15 other ma-
jor organs systems. From the isotope content of each tissue, we
determined IC content, blood flow rate, vascular transit time,
and fractional uptake of IC (F1). In addition, glomeruli were iso-
lated from renal cortex to assess IC uptake in glomerular versus
renal nonglomerular tissue. We found that 1) for kidney, IC de-
livery rate, capillary hydrostatic pressure, and capillary ultrafil-
tration rate are less important than the plasma IC concentration
in determining IC uptake; 2) for each organ studied, the principal
determinant of IC uptake per gram of tissue, at any given P1, is
vascular volume per gram of tissue; 3) tissue vascular volume per
gram of tissue may determine IC uptake per gram of tissue be-
cause tissue vascular volume determines the capillary surface
area in contact with circulating IC or because tissue vascular vol-
ume determines tissue vascular transit time, at any given tissue
blood flow rate.
Quelques determinants hemodynamiques de Ia sequestration
d'immuns-complexes par le rein. Ce travail a été entrepris pour
aider a clarifier Ia relation entre les phénomènes hémodyna-
miques capillaires et Ia captation tissulaire des immuns com-
plexes circulants (IC). Chez 23 chiens des IC solubles, marquós
par 1251 de serum albumine bovine (BSA) et anti-BSA de lapin,
ont éte administrés par perfusion intraveineuse a debit constant
et Ia captation d'lC par un rein normalement perfuse a été corn-
parée a celle du rein controlatéral dont le debit sanguin (RBF) a
Cté change par Ia constriction de l'artère ou l'augmentation de Ia
pression urétérale. Chez ces mêmes animaux Ia captation d'IC
par d'autres organes a été mesurée. Au cours de l'administration
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d'IC des microsphéres de 85Sr ont eté injectees pour mesurer les
debits cardiaque et tissulaires et des hématies marquees par 51Cr
ont été administrées pour évaluer le volume vasculaire. A Ia fin
de l'administration d'IC des échantillons de tissu renal et de 15
autres organes importants ont été prélevés, A partir des radio-
activités de chaque tissu, nous avons déterminé Ic contenu en
IC, le debit sanguin, le temps de transit vasculaire, et Ia capta-
tion fractionnelle d'IC (F1). De plus, des glomerules ont ete
isolés du cortex renal afin de comparer Ia captation par les tissus
glomerulaire et non glomerulaires. Nous avons constaté que 1)
pour le rein Ic debit d'IC délivré, Ia pression hydrostatique capil-
aire et le debit d'ultrafiltration capillaire sont moms importants
que Ia concentration plasmatique d'IC dans le déterminisme de
Ia captation d'IC; 2) pour chaque organe étudié Ic principal dét-
erminant de Ia captation d'IC par gramme de tissu, pour une P1c
donnée, est le volume vasculaire par gramme de tissu; 3) le vol-
ume vasculaire par gramme de tissu peut determiner Ia captation
d'IC par gramme de tissu puisque le volume vasculaire deter-
mine Ia surface capillaire en contact avec l'IC circulant ou bien
parce que Ic volume vasculaire du tissu determine le temps de
transit vasculaire pour chaque valeur du debit sanguin.
The physical and biochemical events which lead
to the trapping of circulating immune complexes
(IC) are, at present, only poorly understood. It has
been suggested that high capillary ultrafiltration
rate, as occurs naturally in the glomerulus [1] or as
might be induced by release of vasoactive amines
from platelets or mast cells, is an important de-
terminant of IC-trapping [2—4]. Enhanced capillary
ultrafiltration rate causes the plasma concentration
of nonfilterable solutes to increase at the site of ul-
trafiltration and causes the capillary flow velocity to
diminish. These effects of ultrafiltration increase the
concentration of IC in contact with capillary endo-
thelium and prolong contact time between circulat-
ing IC and endothelium. These events, singly or in
combination, might increase the rate at which circu-
lating IC are trapped by capillary endothelium.
If this hypothesis is correct, it follows that plasma
IC concentration and capillary hemodynamic
events, such as hydrostatic pressure, flow rate, and
tissue vascular transit time, each of which can af-
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fect either capillary ultrafiltration rate or contact
time of IC with endothelial cells, might be important
determinants of tissue uptake of circulating IC. The
present study examines several aspects of this prob-
lem by assessing the relationship between arterial
plasma IC concentration, capillary hemodynamic
events, and IC-trapping by the kidney and other or-
gans.
Methods
Preparation of i/n mnune coin plexes
Crystallized bovine serum albumin (BSA; Miles
Laboratory) was labeled with iodine 125 (1251) as
previously described [5]. Labeling efficiency was
about 45%, and specific activity ranged from 20 to
30 MCi/mg. AntiBSA antibody was produced by im-
munizing New Zealand rabbits, as previously de-
scribed [5]. The sera were tested for antibody con-
centrations by the quantitative precipitin method.
IC were formed by combining the rabbit antiserum
with '251-BSA at equivalence and incubating for 1 hr
at 37° C and then at 48 hr at 4° C. The resulting pre-
cipitate was centrifuged, washed, and then in-
cubated with 0.01 M phosphate buffered (pH, 7.0)
0.9% saline (PBS) to which five times the antigen
excess was added. The solution was stirred for 30
mm at room temperature, then centrifuged at
x 1 ,000g for 10 mm and the precipitate discarded.
About one half of IC precipitate was solubilized by
this method. Gel filtration on Sephadex G-200
showed that 70 to 90% (mean, 82%; N = 5) of 125I.
BSA in this solution was incorporated into a single
dominant peak composed of complexes  19S. The
remainder of the 1251-BSA was uncomplexed. Mer-
thiolate (1/10,000) was added to all batches to retard
bacterial growth. The IC were stored at 4° C and
used within 2 weeks. BSA-rabbit antiBSA IC pro-
duced in this fashion are biologically active, as
shown by their ability to fix complement and in-
crease capillary permeability and by their pattern of
systemic uptake [51.
Surgicalpreparation
Twenty-three mongrel dogs weighing 5 to 15 kg
were deprived of food and given sodium iodide in
drinking water approximately 20 hr prior to study.
They were anesthesized with i.v. pentobarbital (30
mg/kg) and given additional small doses as required
to maintain a constant level of anesthesia. An endo-
tracheal tube was inserted and connected to a con-
stant-volume positive-pressure ventilator. Cathe-
terization of the following blood vessels was per-
formed: right brachial vein (for constant infusion of
IC solution); right femoral vein to superior vena
cava (to measure concentration of IC delivered to
the lungs); left femoral vein (for constant infusion of
normal saline at 4 mL/min and creatinine to measure
creatinine clearance; this infusion was begun at the
start of the surgical preparation); left femoral artery
(to measure blood pressure); right femoral artery (to
obtain arterial blood samples); and left carotid ar-
tery (to catheterize left ventricle for injection of mi-
crospheres [strontium 85 (85Sr), 15 tm, 3-M Compa-
ny, St. Paul, Minn.]). Both kidneys were exposed
by a midline abdominal incision and freed of their
perirenal attachments, and both ureters were can-
nulated. In 16 experiments, a Blalock clamp was
loosely placed around either the right or left renal
artery in preparation for application later in the ex-
periment. In four experiments, renal interstitial
fluid was collected from the subcapsular space from
both kidneys to assess for entry of iodine 125 (1251)
into the interstitial space [5].
Experimental protocol
About 45 mm before starting the experiment
proper, about 20 ml of blood was removed, and the
red blood cells (RBC) were labeled with 30 Ci of
chromium 51 (51Cr).
Control period. The orifices of both ureteral cath-
eters were fixed at the level of the superior surfaces
of the kidney. This was defined as ureteral pressure
(UP) = 0 mm Hg. Two 15-mirL periods of urine col-
lection from both kidneys were begun 30 mm before
the IC infusion to measure creatinine clearance. In
the 16 experiments in which RBF was changed by
manipulating renal perfusion pressure, the Blalock
clamp was then adjusted until urine flow rate from
the experimental kidney was approximately one
half that observed in the contralateral control kid-
ney. The mean urine flow rate from the control kid-
ney during the control period was 1.3 0.1 mllmin.
After establishing steady-state urine flow rates (15
to 30 mm of adjustment), the experimental period
was begun. In those experiments in which RBF was
changed by raising UP, the orifice of the ureteral
catheter of either the right or left kidney was raised
to 42 cm above the superior surface of that kidney
so that when the catheter was completely filled with
urine, UP = 30 mm Hg. After steady-state urine
flow rates were established (15 to 30 mm), the ex-
perimental period was begun.
Experimental period. The IC infusion was given
as follows: Each animal received 10 to 20 /LCi of IC
(6 to 8 mg of protein) in 30 ml of PBS. Approximate-
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ly one third of the IC solution was infused over 5
mm; the remainder was given over the next 55 mm
by constant infusion pump. Twenty minutes before
completing the IC infusion, the 5tCr-RBC were in-
fused. The microspheres (1 to 3 Ci) were sus-
pended by ultrasonic mixing in 5 ml of saline to
which 1 drop of Tween-80 was added, and they
were infused as follows: one third of the micro-
spheres were given by bolus infusion at 10, 30, and
50 mm, during the IC infusion. Arterial samples
were obtained during the 10- and 50-mm samples to
measure cardiac output.
At the conclusion of the IC infusion, the animals
were killed, and the following tissue samples were
taken for analysis: renal cortex (Three midcoronal
sections about 0.5-cm thick were taken from both
kidneys, From each coronal section, two cubes of
full-thickness cortex about 1-cm wide were cut.
From each section, one of the cubes was divided
into outer and inner cortex and taken for isotope-
counting, and the other cube was taken for isolation
of glomeruli by sieving techniques [5, 6].), brain
(frontal cortex), choroidplexus, thymus, large bow-
el, small bowel, stomach, fat (peritoneal), dia-
phragm, skin (abdominal), gonads (ovaries or tes-
tes), adrenal gland, heart (ventricle), spleen, liver,
and lung. Samples weighed 200 to 600 mg, except
for choroid plexus where the entire organ was taken
for analysis. The entire weight of lung, spleen,
stomach, large and small bowel were also measured
so that fractional uptake of IC (F1) in lung and liver
could be calculated, as discussed below.
Specialprotocol
To assess whether the tissue distribution of 1251
observed after the infusion of the '251-BSA-rabbit
antiBSA IC might be importantly affected by an ab-
normal sequestration of free '251-BSA in tissues, in
eight separate experiments we examined the
steady-state distribution of 1251-BSA in liver,
spleen, and kidney. '251-BSA (3 to 5 MCi) was in-
fused i.v. and allowed to circulate for 2 hr. At that
time, samples of liver and spleen were obtained by
clamping the edge of the organ, incising the tissue,
and allowing it to fall directly into liquid nitrogen to
freeze the tissue quickly and thereby prevent fluid
loss. Kidney was removed without fluid loss by
clamping the hilar structures prior to removal. The
kidney was then frozen. The 1251 concentration of
tissue and simultaneously obtained plasma samples
were then determined and the tissue-to-plasma 1251
ratios calculated.
Analytical methods
Radioisotope counting was done in a refrigerated
automatic Packard dual channel gamma counter.
Counts for each isotope were corrected for the pres-
ence of the other isotopes by using appropriate cor-
rection factors and simultaneous equations, which
were solved by a program adapted to a Monroe 1860
desk top computer. Protein concentrations of the IC
preparations were done by the Lowry method. Oth-
er analytical techniques are as previously reported
[71.
Ca/c,, Ia tiOilS
Fraction of glomeruli isolated from sample of
cortex. The fraction of glomeruli isolated from
sample of cortex [5, 6] = (85Sr cpm in glomerular
isolate/g of cortex from which glomeruli isolated)!
(85Sr epinig of a comparable sample of cortex),
where cpm = counts per mm.
IC content of tissue. The IC content of tissue
(Qic) = total 1251 cpmlg of whole tissue — vascular
space correction.
Vascular space correction. The vascular space
correctio& = [51Crcpm!g of tissue] . [(1251 cpmlg of
blood)/(51Cr cpmlg of blood)].
Cardiac output. The cardiac output (CO) = Sr
cpin injected/I(85Sr cp,nlg of blood) x t] = g!min,
where 85Sr cpm!g of blood is determined from an
arterial blood sample withdrawn by constant with-
drawal pump at the rate of 10 mI/mm for time t (in
these experiments, t = 60 sec) beginning 10 sec be-
fore the microsphere infusion, which was given
over approximately 10 sec.
Fractional uptake of im,nune complexes. The
fractional uptake of immune complexes (F1) = Q1I
(Pw x CO x R), where Pw = mean arterial plasma
IC concentration. For each experiment, this was
calculated by determining the area under the curve
of a plot of plasma 1251 cpm!g vs. time and dividing
this value by the time interval. R = the ratio [(85Sr
cp,n/g of tissue sample)/85Sr cpm injected].
To calculate F1 of lung, c was measured from
superior vena cava blood, R was assigned a value of
1.00, and CO was divided by total lung weight.
These modifications of the equation are necessary
because the lung receives immune complexes at a
slightly higher concentration than the rest of the
body does and because microspheres injected ar-
terially cannot be used to measure lung blood
The vascular correction assumes that the arterial hematocrit
is the same as the intraorgari hematocrit. In fact, the intrarenal
hematocrit (renal cortex red cell volume/renal cortex blood vol-
ume) and the whole body hematocrit (whole body red cell vol-
ume/whole body blood volume) are both about 90°/ of the arterial
hematocrit [8, 9]. This small difference between large vessel and
small vessel hematocrit has no important effect on the vascular
correction and, therefore, was ignored.
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flow because the microspheres are removed en
route to the lungs. Lung, however, receives the
entire cardiac output. Knowing these variables
permits calculation of F1 by lung [6].
To calculate the F1 of liver, the total microsphere
(in counts per mm) in spleen, stomach, large and
small intestine are added to the total microsphere
(counts per mm) of liver. This modification of the
equation is necessary because the microspheres
measure only hepatic artery flow. The remainder of
blood flow to liver is via the portal vein which re-
ceives venous return from gut and spleen. Thus, mi-
crospheres in these splanchnic organs also repre-
sent blood flow to liver.
F1 calculated as above is an apparent fractional
uptake of IC, since the fraction of arterial plasma
1251 counts which represent IC that are susceptible
to trapping is less than the actual 125j plasma con-
centration and may be less than the actual arterial
plasma concentration of IC as assessed by gel filtra-
tion, since not all IC may be susceptible to trapping
[101. By the end of the IC infusion, only one third to
one half of the 1251 counts in arterial plasma repre-
sent IC (range of three observations), whereas ini-
tially as much as 90% of the 1251 counts represent
IC. Thus, the true F1 is greater than F1 calculated
as above. The F1 ratio (F1 of a given tissue/F1
control kidney outer cortex, however, should be a
reasonable estimate of the true F1 ratio since the
term P1 appears in both numerator and denomina-
tor and therefore cancels from the ratio.
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The F1 ratio for liver is an underestimate since
the liver receives IC at a lower concentration than
other organs do, because about three fourths of he-
patic blood flow is via the portal vein [11] and some
of the IC have been removed from the blood during
passage through gut and spleen. Nevertheless, por-
tal blood flow is largely from gut [11], which, as
will be shown, has a relatively low F1. Thus, the
liver F1 ratio, although an underestimate, is a rea-
sonable index of the true liver Fi( ratio.
Tissue vascular transit time. Tissue vascular
transit time (TT) = V/F, where V = fraction of tis-
sue volume which is vascular volume, vascular vol-
ume is calculated from the 51Cr-RBC space in tis-
sue, as described above, and F = blood flow per
gram of tissue = CO x R. TT calculated as above is
not a true tissue vascular transit time since TT is
calculated from tissues in which blood was allowed
to drain spontaneously. Nevertheless, the vascular
volume of these excised tissues is proportional to
the vascular volume of these same tissues in vivo,
as shown in Fig. 1. Furthermore, the measurement
of tissue blood flow with the microsphere technique
is valid under the hemodynamic conditions imposed
by immune complex infusion, since we found no
evidence of excessive shunting of microspheres
through the systemic vascular circuits. This was
shown by the fact that only 2.8 0.5% of the micro-
spheres injected into the left ventricle was found in
lung, and over one third of this microsphere radio-
activity can be accounted for by bronchial artery
30
S Liver
S
Lung
5
Y = O.62x + 2.2
0.88
P <0.05
10 20 30 40 50
Previous studies: mean tissue vascular volume (in vivo estimates), %
Fig. 1. Relationship between tissue vascular volume of excised tissues and the vascular
volume oft/me same tissues, in vivo. The mean values of vascular volume for excised tissues
are from the present study. The in vivo values are mean values previously reported in the
literature: brain [12], heart [131, kidney [14], liver [151, and lung [16]. The vascular volume
for brain is based on studies in man. All of the other vascular volumes are based on studies in
the doe.
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blood flow [11]. The validity of the microsphere
techniques in the present experimental setting is al-
so supported by a comparison of previously report-
ed microsphere data on tissue blood flow in the dog
[11] with the mean values of the present study. This
comparison showed excellent agreement (r = 0.97,
P < 0.01). Thus TT calculated as above is a rea-
sonable index of the true tissue vascular transit
time.
Results
All mean values are shown 1 SEM.
Svste,nic uptake of immune complexes. IC were
infused by giving one third over a 5-mm period as a
loading dose and two thirds over the next 55 mm by
constant infusion. On the average, this achieved
nearly steady-state conditions in the vascular com-
partment, since for all experiments the mean ratio
of the 125J counts per gram of blood at 50 mm, to the
125J counts per gram of blood at the completion of
the loading dose (5 mm) was 1.18 0.06. Virtually
all (> 98%) of the 125J in plasma obtained at the end
of the experiment was trichloracetic acid precipi-
table, and < 2% of the 125j infused was excreted in
the urine during the experiments (observations from
three randomly selected experiments). Thus, there
was no evidence of important loss of the 125! from
the labeled proteins. We can conclude, therefore,
that during the period of constant infusion, labeled
proteins were leaving the vascular space at a rate
almost equal to the rate of infusion. Since 70 to 90%
of the 1251 infused represented labeled IC, it follows
that almost all of the labeled proteins leaving the
vascular space during the IC infusion represented
the systemic uptake of IC. Finally, since two thirds
of the IC solution was given during the period of
constant infusion, it follows that about two thirds of
the IC infused were taken up systemically.
Table 1 shows the pattern of systemic uptake of
the infused IC. The data in Table 1 were derived as
follows: The ratio of the 125j counts per gram of a
given tissue (corrected for the vascular space 125!
counts) to the 1251 counts per gram of control kidney
outer cortex (corrected for vascular space 1251
counts) of the same animal was determined for each
tissue in each animal. The values shown in Table 1
are the mean of the individual ratios for each organ.
The data are expressed as the ratio of 125Jcontent
in a given organ to that of renal cortex of the same
animal, rather than as the absolute 1251 counts per
gram of each tissue, because the dose of complex
infused varied from animal to animal. This was un-
avoidable because, although the specific activity of
the IC mixture was known, the percent of the 1251
BSA incorporated into complexes declined with
time of storage (about 5 to 15% per week, range of
three observations), and it was not possible to per-
form gel filtration analysis prior to each experiment.
The tissue distribution of 125j shown in Table I, is
not importantly affected by catabolism of the
trapped immune complexes with release of the 125!
label into the extracellular fluid. If this process had
occurred to any significant extent, the 125! would
have to be either in blood or urine (the animals were
given sodium iodide prior to the experiments; thus,
free lSSj was not taken up by the thyroid gland). As
discussed above, however, only trivial amounts of
free 1251 were found in blood and urine. It is also
unlikely that the tissue distribution of 125j shown in
Table 1 is importantly affected by abnormal tissue
retention of '251-BSA. This is shown by the special
protocol" studies examining the steady state tissue!
plasma distribution of 1251-BSA in the organs princi-
pally responsible for the clearance of IC from
plasma. From these experiments, the following
mean ratios for 125J were obtained: renal cortex!
plasma = 0.27 0.02, liver/plasma 0.32 0.03, and
spleen/plasma 0.21 0.02. These tissue-to-plasma
ratios are those to be expected from the appropriate
distribution of albumin in the tissue vascular and in-
terstitial space. These ratios contrast sharply with
the corresponding tissue-to-plasma ratios for 1251
measured at 1 hr following the infusion of the 125j
BSA-rabbit anti-BSA IC. These ratios were: renal
outer cortex/plasma = 0.90 0.14, liver/plasma =
1.62 0.25, and spleen/plasma = 2.59 0.45,
These ratios are many fold higher than those ob-
served for the tissue-to-plasma distribution of 125j.
BSA (a protein that does not deposit in tissue) and,
thus, indicate the presence of 1251-labeled IC which
have been trapped and are tissue-bound (fixed IC
[5]).
The data in Table 1 show that the kidney is a ma-
jor site of IC uptake since only liver, spleen, and
lung had higher concentrations. The findings in
Table 1 are consistent with previous observations
on the pattern of systemic uptake of biologically ac-
tive IC [5, 10, 17—191.
Table 2 shows the mean of the individual F1( ra-
tios (F1 of a given tissue/F1 of control kidney outer
cortex of the same animal) for all tissues studied. As
can be seen, most tissues have F1 ratios greater
than 1.00. That is, per unit of blood flow, these tis-
sues trap more IC than does control kidney outer
cortex. The mean value for F1c for control kidney
outer cortex from all experiments was 0.021
0.006.
For lung, it was possible to directly assess the F1
since the 1251 content of both superior vena cava and
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Table 1. Ratio of 1251 in a given tissue to that of renal outer cortexa, S
Frontal brain
Tissues with mean 125J countslg ratio significantly less than 1.00 (alt P <
Choroid plexus Heart Adrenal
0.001)
Thymus Large bowel
0.025 0.004
N=18
0.15 0.05 0.12 0.009 0.28 0.03
N=17 N=17 N=15
0.18 0.02N=l4
0.22 0.02
N=22
Small bowel Stomach Fat Diaphragm Skin Gonads
0.20 0.01
N=24
0.29 0.02 0.08 0.01 0.22 0.04
N=22 N=15 N=18
0.14 0.02
N=16
0.15 0.01
N=17
Tissues with 125J counisig ratio significantly greater than 1.00
Lung Liver Spleen
2.09 0.19 3.15 0.64 4.18 0.66
N=22 N=23 N=23
P < 0.001 P < 0.01 P < 0.001
a The 1251 counts of each tissue is corrected for the 125J counts in the vascular space.
iS N = number of experiments in which measurements were made.
arterial blood was measured during the IC infusion.
We found a small, but insignificant gradient for 125J
across the lungs [(83.9 19.7] x lO vs. (83.1
19.21 x lOs, cpm, P > 0.5]. This outcome could
have been expected for the following reasons: 1)
Lung F, is relatively small (Table 2), and it is diffi-
cult to detect accurately small differences between
two large numbers (the 1251 counts in superior vena
cava and arterial blood), 2) IC probably are not ade-
quately mixed in superior vena cava blood since the
IC are infused only a relatively short distance below
the superior vena cava.
The above example also serves to emphasize the
difficulty in measuring accurately the F1 by mea-
Liver
8.97 1.20
P < 0.001
N = 20
Stomach
13.6± 1.98
P < 0.001
N = 19
Spleen
13.8 2.76
P < 0.001
N = 21
Fat
3.82 0.91
P < 0.01
N = 13
suring the gradient of 125J across a given organ
since, like lung, most organs have a low F1. At the
same time, the above example underscores the val-
ue of the present method for estimating F1. That is,
although the 125! gradient across an organ may be
difficult to measure, the 125J trapped in tissue [cor-
rected for nonfixed 125J [5] ] divided by the tissue
delivery rate of 125j, is relatively easy to measure.
Effect of reduced renal blood flow on immune
complex uptake by the kidney. Figs. 2 and 3 show
for outer and inner cortex, respectively, the rela-
tionship between the ratio of RBF (RBF experimen-
tal kidney/RBF control kidney) and the ratio of IC
uptake (IC uptake of experimental kidney cortex/IC
Large bowel
1.92 0.34
P < 0.02
N = 19
Skin
10.1 1.61
P < 0.001
N = 13
Small bowel
2.61 0.39
P < 0.001
N = 22
Gonads
2.51 0.43
P < 0.001N 16
Table 2. Ratio of the fractional uptake of immune complexes (F,) in a given tissue to the fractional uptake of immune complexes in renal
outer cortexa
Tissues with mean F1 ratios significantly greater than 1.00
Thymus
9.89 1.92
P < 0.001
N = 12
Diaphragm
4.31 0.77
P < 0.01
N= II
Tissues wit!, mean F, ratios significantly less than 1.00
Frontal Choroid
brain plexus
0.15 0.04 0.056 0.027
P < 0.001 P < 0.001
N=17 N=14
Tissues with mean F, ratios not significantly different from 1.00
Heart Lung Adrenal
0.64 0.17 1.01 0.17 0.72 0.20
0.05<P<0.1 P>0.9 0.1<P<0.2
N=14 N=23 N=14
a N = number of experiments in which measurements were made.
0.3 -
0.2
0.1
I I I I I I I I I
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.91.0 1.1 1.2 1.3 1.4
mSr counts/q ratio )experimenta) kidney/control kidney)
Fig. 2. Effect of changes in renal outer cortical blood flow on
renal outer cortical immune complex uptake. Each experiment is
represented by a single point or by a pair of points which arejoined by an arrow (as discussed in Text). The ttSr ratio repre-
sents the ratio of the renal blood flow in the experimental versus
the control kidney. The 1251 ratio (corrected for vascular 125J
counts) represents the ratio of immune complex uptake in the
experimental versus control kidney.
uptake of control kidney cortex). Each experiment
is represented by a single point.2 As can be seen, in
virtually all experiments with 85Sr ratios < 1.00 the
2 This was true except for four experiments in which renal in-
terstitial fluid was collected simultaneously from the experimen-
tal and control kidney to correct cortical 129 counts for entry of
diffusible t25J (as labeled antigen, IC or free 1251) into the cortical
interstitial space. The entry of these labeled molecules into the
interstitial space results in an overestimate of the amount of IC
which has been trapped and fixed to renal cortex and, therefore,
capable of inducing tissue damage. The four experiments in
which renal interstitial fluid was collected are identified by the
points joined by an arrow. The arrow indicated the magnitude
and direction of the change in the 125J ratio as a result of the
correction for entry of diffusible 125J into the interstitial space. As
can be seen, in the present experimental setting, the 1251 ratios
are not greatly affected by this correction. Furthermore, as in our
previous report, the interstitial space correction was relatively
small (mean c 15% of total 1251 content of tissue). Since we pre-
viously found that the vascular and interstitial space corrections
for 1251 are approximately equal [5], we can conclude that, on the
average, in the present study about 85% of the 125J counts of renal
cortex (corrected for vascular space 125J counts) represents IC
which are trapped by renal cortex and tissue bound.
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C 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4
55Sr counts/g ratio )experimental kidney/control kidney)
Fig. 3. Effect of changes in renal inner cortical blood flow on
renal inner cortical immune complex uptake. The conventions
used are the same as in Fig. 2.
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IC uptake of the experimental kidney cortex is less
than the simultaneous IC uptake of the contralateral
control kidney cortex. The regression lines drawn
through these points show slopes significantly dif-
ferent from 0.00 for both outer and inner cortex.
For experiments with 55Sr ratios greater than 1.00,
the data are inadequate in amount for analysis.
In both the control and experimental kidney, out-
er cortex appeared to trap IC in higher concentra-
tions than did inner cortex. The mean of the individ-
ual ratios: (t25I cpm/g of outer cortex)/(t551 cpm/g of
inner cortex) for control and experimental kidneys
was the same (1.16 0.04). Both ratios are signifi-
cantly greater than 1.00 (P < 0.001 for both). This
interpretation, however, assumes that the inter-
stitial correction for t25J (see footnote 2) for inner
and outer cortex is similar.
Although IC uptake diminished as RBF was re-
duced, uptake of IC fell proportionately less than
did RBF (and delivery rate of IC). Thus, as shown
in Fig. 4, Ftc in renal cortex increased as RBF was
decreased. Fig. 4 shows the relationship between
the ratio of RBF (RBF of experimental kidney/RB F
of control kidney) and the ratio of Fic (Ftc of experi-
mental kidney cortex/F1 of control kidney cortex).
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Fig. 4. Relationship between the ratio of renal blood flow in the
experimental versus control kidney and the ratio of fractional
uptake of immune complexes in the experimental versus control
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21 experiments. The dashed line indicates the change in F1
which would have to occur in the experimental kidney to main-
tain immune complex uptake in the experimental kidney at the
same level as the normally perfused contralateral control kidney.
The values for both outer and inner cortex are
shown.
The increase in renal cortex F1 with decreasing
RBF could have been the result of a prolongation of
TT. It was not possible to test this hypothesis for
renal cortex because of the relatively small range of
F1 observed in the kidney and the imprecision in
the method used to measure TT. When all tissues
were considered together, however, a wide range of
values for F1 and TT were observed. These are
compared in Fig. 5, which shows the mean values
for TT and F1 for each organ examined. As can be
seen, a high degree of correlation was found. Since
the term, tissue blood flow, appears, however, in
the denominator of both the expression for TT and
F1, the fact that the two variables are correlated
indicates only that a cause-and-effect relationship
has not been excluded by this analysis.
A second possible explanation for the rise in renal
cortex F1 as RBF was reduced (i.e., the relative
stability of renal IC uptake in the face of decreasing
IC delivery rate) is that the rate of IC-trapping may
be determined largely by the concentration of IC in
contact with capillary endothelium. To assess this
possibility, in each experiment we examined the
relationship between the mean arterial plasma 1251
concentration during the IC infusion (an index of
the mean plasma IC concentration [P1] during IC
infusion) and 1251 cpm per gram of control kidney
cortex (corrected for 1251 counts in vascular space).
This relationship is shown in Fig. 6. As can be seen,
in general, the higher the P, the greater the amount
of IC trapped by cortex. The same approximate
linear relationship was observed for all organs (r>
0.8 for all organs); of course, the slope of the line
describing this relationship, however, varied from
organ to organ according to IC content per gram of
tissue. Those tissues with high concentrations of 1251
exhibited steeper slopes than did those with low
concentrations of 125J
The reason for the differences from organ to or-
gan in the amount of IC trapped per gram of tissue
at any given arterial P1 appears to be related to dif-
ferences in the capillary mass per gram of tissue.
This is suggested by the relationship shown in Fig. 7
in which, for each tissue, the mean ratio of 1251
counts per gram of the given tissue to that of renal
outer cortex (data of Table 1) is shown in relation-
ship to the mean tissue vascular volume (an index of
capillary mass) for each organ. As can be seen, in
general, the greater the capillary mass per gram of
tissue, the greater is the amount of IC trapped per
gram of tissue.
This analysis suggests that under condition of
normal tissue perfusion the amount of IC trapped
per gram of tissue, at any given P1, is determined
by the capillary surface area in contact with the cir-
culating IC. The relationship, however, between
tissue vascular volume and IC trapped per gram of
tissue, shown in Fig. 7, could also be explained by
the relationship demonstrated between TT and F1
(Fig. 5). This can be shown as follows: From Fig. 7:
IC uptake/g of tissue = k V (1)
where k is the proportionality constant and V is
vascular volume per gram of tissue. Since IC uptake
per gram tissue = F >< F1, where F =blood flow
per gram of tissue, it follows that
F X F1 = k V
Rearranging Equation 2,
but
F1 = k V/F
2)
(3)
V/F=TT (4)
2.
3.
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0.54 0.20% vs. 0.49 0.23%. Thus, as we have
previously observed, during acute infusions of IC or
IC-like macromolecules, the vast majority of IC
trapped by the kidney are trapped in nonglomerular
sites [5, 6].
Hemodynamic events during immune complex in-
fusion. Blood pressure fell significantly during the
IC infusion from a mean value of 103 5 mm Hg
during the first one third of the IC infusion to a
mean value 76 4 mm Hg during the last one third
of the IC infusion (P < 0.001). During IC infusion,
cardiac output increased modestly, but significant-
ly,from 970 110 g/min at 10 mm to 1,320 l4OgI
mm at 50 mm.
Thus, the decrease in systemic blood pressure
was the result of a fall in peripheral resistance. Oth-
er investigators [20, 21] and we ourselves [5, 6] have
previously noted a fall in systemic blood pressure
during the infusion of biologically active com-
plexes. Presumably, the fall in systemic blood pres-
sure is a result of IC-induced release of vasoactive
substances.
Glomerular filtration was not significantly dif-
ferent in the control versus experimental kidney pri-
orto IC infusion (19.6 1.7 vs. 20.2 l.9mllmin).
During the IC infusion (after raising ureteral pres-
sure or lowering renal perfusion pressure, in the ex-
perimental kidney), GFR was significantly lower in
the experimental kidney versus the control kidney
(9.0 1.1 vs. 15.3 1.6, P < 0.001).
see Methods. Combining Equation 3 and 4, we ob-
tam,
F1 = k TT
This is the relationship demonstrated in Fig. 5.
Thus, the relationship between F1 and TT dem-
onstrated in Fig. 5 follows from the relationship be-
tween IC uptake and V demonstrated in Fig. 7.
This analysis, however, does not establish which
relationship is primary. That is, at any given P1 and
tissue blood flow rate, does V determine IC uptake
because V is proportional to capillary surface area
or because V determines TT?
Glomerular versus renal non glomerular uptake of
immune complexes. To assess the site of IC uptake
within the kidney, in 19 experiments glomeruli were
isolated from both the control and experimental kid-
ney. The mean recovery of glomeruli from a given
cortical sample was 24.0 0.8% in control kidneys
and 23.5 2.1% in experimental kidneys. The per-
cent of cortical 1251 found in the glomerular isolates
in the control versus the experimental kidneys was
Discussion
In the present study, biologically active IC were
infused i.v. under conditions in which RBF was
changed in one kidney (the experimental kidney) by
constricting the renal artery or raising ureteral pres-
sure. IC uptake by the experimental kidney was
compared to the simultaneously determined IC up-
take by the contralateral (control) kidney, and the
relationship between the observed changes in RBF
and renal IC uptake was examined.
The present study appears to be a valid assess-
ment of the effect of RBF reductions on renal IC
uptake for the following reasons: 1) The dose of IC
used was far below the concentrations which are
thought to cause saturation of the reticuloendothe-
hal system [19] and apparently below the concentra-
tions which cause saturation in other tissues, since
we found that the tissue IC content for all tissues
studied, including kidney cortex (Fig. 6), increased
progressively with increasing P'. Thus, we assume
that in the present study the effect of RBF (delivery
rate of IC) on IC uptake was not obscured because
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tissue binding sites for IC were saturated. 2) The IC
were infused for only 1 hr. The renal catabolism of
trapped IC is probably minimal over this time peri-
od [5, 221; thus, at the end of 1-hr IC infusion, the
tissue IC content is determined principally by IC
uptake. 3) The present approach uses a valid means
for estimating tissue IC content, since we have pre-
viously shown that the IC content of renal cortex,
calculated as total 125J cprnlg of tissue minus the
vascular 125J cpm/g of tissue, is a close estimate of
the amount of IC which has been trapped and tis-
sue-bound [51. 4) The microsphere method validly
measures tissue blood flow under conditions of IC
infusion, as discussed in the Methods section.
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r =0.84
P < 0.001
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The present study shows that reductions in RBF
result in decreased renal IC uptake. The effect was
similar whether RBF was reduced by renal artery
constriction or by ureteral pressure elevation (Figs.
2 and 3). Since these maneuvers have opposite ef-
fects on capillary hydrostatic pressure3, it seems
likely that capillary hydrostatic pressure, itself, is
not a critical determinant of IC-trapping.
Although renal IC uptake decreased with de-
creasing RBF, the fall in IC uptake was proportion-
ately less than the fall in IC delivery rate to the kid-
ney. Thus, the amount of IC trapped per unit of
blood flow rose, and, as a consequence, renal F1
increased. Indeed, for those experiments in which
only moderate reductions in RBF occurred, the in-
crease in F1 in the experimental kidney was suf-
ficient to account for an IC uptake in the experimen-
tal kidney which was only slightly less than that of
the contralateral control kidney.
The increase in F1 with decreasing RBF could
have been due to a change in capillary hemo-
dynamics in which, as renal blood flow decreased,
TT was prolonged resulting in increased contact
time between circulating IC and capillary endothe-
hum. In addition, it has been shown that decreasing
glomerular capillary flow rate increases the fraction
of macromolecules transferred across the glomeru-
lus, apparently by increasing time for macromole-
cule diffusion 26II. These possible effects of de-
creased RBF might have led to the observed in-
crease in renal F1. It was not, however, possible to
evaluate this question accurately for kidney, since,
as discussed in Methods, the method used to calcu-
late TT does not reliably detect small changes in
TT. It was possible, however, to evaluate the rela-
tionship between F1 and TT over a wide range of
values by examining this relationship for all tissues
studied.
As shown in Fig. 5, there was a strong correlation
between TT and F1. This correlation, however, can
only be interpreted as evidence that TT cannot be
discarded as a possible determinant of F1. The fact
that F1 and TT are correlated could be a causal
relationship or could reflect entirely the fact that the
term "tissue blood flow" is in the denominator of
We have shown previously that renal artery constriction and
ureteral pressure elevation of the magnitude used in this study
change renal subcapsular pressure (RSCP), an index of pen-
tubular capillary pressure [23], significantly. During renal artery
constriction the mean decrease in RSCP was —5 mm Hg 1241.
During ureteral pressure elevation, the mean increase in RSCP
was +20 mm Hg 125].
both the expression for TT and the expression for
F1. Thus, even if there were no causal relationship
between F1 and TT, there is a natural tendency for
the two values to change together as the term "tis-
sue blood flow" changes.
A second possible explanation for the rise in F1
(and the tendency of renal IC uptake to remain
nearly constant) as RBF is diminished, is that renal
IC uptake might be proportional to the concentra-
tion of circulating IC in contact with capillary endo-
thelium. If this were true, the rise in F1 with de-
creasing RBF would not be evidence that the avidi-
ty with which IC are being trapped increased with
decreasing RBF. Rather, the increase in F1 would
simply be the mathematical consequence of the fact
that, as RBF is reduced, IC uptake is held nearly
constant (by a nearly constant intraorgan P1) as IC
delivery rate is decreased.
The hypothesis that renal IC uptake is principally
determined by arterial P1 could explain the obser-
vation that small RBF reductions are associated
with only small reductions in renal IC uptake, while
larger RBF reductions are associated with sub-
stantial reductions in renal IC uptake. The rationale
is as follows: Under conditions of normal or near
normal renal perfusion, P1 is relatively constant
within the kidney, since only a small fraction (prob-
ably less than 5%) of the 1C delivered to the kidney
is removed in a single passage through the kidney.
With modest decreases in RBF, only a small further
reduction in P occurs within the kidney; thus, only
small decreases in IC uptake are observed. With
large reductions in RBF, however, the amount of IC
removed from renal plasma becomes a higher frac-
tion of the IC delivered; thus, a greater intrarenal
reduction in P1 occurs. Because of the greater in-
trarenal decline in Plc with large reductions in RBF,
renal IC uptake is decreased substantially.
Evidence supporting the hypothesis that arterial
P'c is an important determinant of renal IC uptake is
provided by the demonstration that IC uptake per
gram of renal cortex was proportional to the mean
arterial plasma 1251 concentration (an index of Pic,
during the IC infusion). A similar linear and signifi-
cant relationship was observed for all other organs,
however; of course, the slope of the relationship be-
tween P1c and tissue IC concentration varied greatly
from tissue to tissue according to the I content of
the given tissue, as discussed in the Results section.
The reason for the differences in IC uptake per
gram of tissue, at any given P1, may be related to
differences in the capillary mass per gram of tissue,
since IC uptake per gram of tissue and tissue vascu-
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tar volume (an index of capillary mass) were corre-
lated (Fig. 7). This suggests that IC uptake per gram
of tissue, at any given P, and tissue blood flow rate
are largely determined by the capillary surface area
per gram of tissue in contact with the circulating IC.
As more rigorously discussed in Results, it is also
possible, however, that the effect of vascular vol-
ume per gram of tissue to affect IC uptake per gram
of tissue is related to the fact that vascular volume
per gram of tissue determines TI, at any given tis-
sue blood flow rate. Thus, if contact time or dif-
fusion time of IC affects IC capillary uptake, vascu-
lar volume per gram of tissue could also exert its
effect on IC uptake by determining TT, at any given
tissue blood flow rate.4
As can be seen in Fig. 7 spleen and liver have
especially high IC concentrations for the level of
vascular volume. For these tissues, however, there
is evidence that tissue-bound macrophages possess
receptors for trapping IC [19, 27]. This may in-
crease the efficiency with which these organs trap
circulating IC and may account for the especially
high tissue IC content at any given P.
The hypothesis that, at any given tissue blood
flow rate, IC uptake per gram of tissue in a given
organ is largely determined by P, and the vascular
mass of that organ, can also explain why normal
glomeruli are not the major intrarenal site of uptake
of iC or Ic-like macromolecules during acute i.v.
infusions of these macromolecules [5, 6]. That is,
glomerular capillary volume is only about one tenth
to one fortieth of the peritubular capillary volume
It should be made clear that tissues which differ with respect
to TT do not necessarily differ with respect to capillary flow ve-
locity. This can be demonstrated as follows:
TT = V/F
Considering flow thru a single tube of cross-sectional
area = A and length = L,
However,
TT = (A)< L)/F
flow velocity (S) = F/A
Substituting Equation 8 into 7 yields:
TT = LIS
Thus, in a tissue with a given vascular volume and blood flow
rate per gram of tissue, TT could be prolonged because of low
capillary flow velocity (5) or because the capillaries have normal
flow velocity but the capillaries are longer (and, therefore, more
narrow) than normal. In either case, TT would be prolonged and
would result in increased contact between plasma IC and capil-
lary endothelium and result in increased time for diffusion of IC
into capillary endothelium with increased permeability.
[28]; thus, if capillary surface area in contact with
circulating IC is an important determinant of IC up-
take, glomeruli would be expected to be a minor in-
trarenal site of IC uptake. Differences in TT, how-
ever, could also explain why the glomeruli are not
the major intrarenal site of IC uptake. That is,
glomeruli have the same blood flow rate as the renal
peritubular capillary system, but because of the
much smaller glomerular vascular volume, TT
through glomeruli is much less than IT through the
peritubular capillary system. Thus, if contact time
of IC with capillary endothelium is a determinant of
IC uptake, glomeruli would be expected to be a mi-
nor intrarenal site of IC uptake.
Two important conclusions follow from the ob-
servation that glomeruli are not the major intrarenal
site of IC uptake during acute i.v. IC infusion: 1) If
glomeruli are the major intrarenal site of IC uptake
in glomerulonephritis, the glomeruli must first be al-
tered in some way so that glomeruli can trap IC
more avidly. 2) capillary ultrafiltration rate is not a
critical determinant of IC uptake since glomerular
capillaries, which exhibit very high rates of capil-
lary ultrafiltration [1], do not avidly trap IC; but the
peritubular capillary system, which exhibits no net
ultrafiltration (i.e., these capillaries apparently un-
dergo net uptake of fluid across their entire length
[29]), apparently trap large amounts of IC.
We do not suggest, however, that capillary ultra-
filtration rate plays no role in the tissue uptake of
IC, since, all other things being equal, an increase in
capillary ultrafiltration rate would locally increase
plasma IC concentration and increase the contact
time of IC with capillary endothelium. These
events, as discussed above, might increase IC up-
take.
The effect of decreased RBF to diminish renal iC
(6) uptake might explain the protection afforded against
glomerulonephritis by conditions such as renal ar-
tery stenosis or ureteral obstruction [30, 31]. Al-
though those observations suggest that severe re-
ductions in RBF are necessary to protect the kidney
from IC-mediated injury, the findings of the present
(8) study, that even modest reductions in RBF result in
decreased renal iC uptake, suggest that less severe
reductions in RBF might also exert a protective ef-
fect against glomerulonephritis. Nevertheless, as a
means to decrease renal IC uptake, the present data
indicate that lowering P1c would be far more effi-
cient than would decreasing RBF.
By contrast, changing tissue blood flow rate to
liver or spleen might greatly affect uptake by these
organs. For example, although IC uptake is only
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moderately flow-dependent in kidney (which has a
low F1c, i.e., a small intraorgan decrease in P1), in
liver and spleen (which have a high F1, i.e., a large
intraorgan decrease in P1), IC uptake might be
highly flow-dependent. That is, increasing flow to
these organs might tend to maintain intraorgan P,
at higher levels (i.e., increasing blood flow might
tend to minimize the intraorgan decrease in P1),
and this might substantially increase the amount of
IC cleared by these organs. Thus, changing blood
flow to liver or spleen might be a means for regulat-
ing the systemic uptake of IC.
In summary, the present study indicates that P1
is a key determinant of IC uptake by the kidney. By
contrast, IC delivery rate, capillary hydrostatic
pressure, and ultrafiltration rate are less important.
Tissues differ greatly with respect to IC uptake per
gram of tissue at any given P1g. These differences
from organ to organ appear to be largely due to dif-
ferences in the vascular volume per gram of tissue.
The effect of vascular volume per gram of tissue
might be mediated through the effects of vascular
volume to determine capillary surface area per gram
of tissue in contact with plasma IC or by the effect
of vascular volume to determine tissue vascular
transit time, at any given tissue blood flow rate.
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